Articles

Find an Article

Filter articles

Applied Filters

Showing 261 to 270 of 273 results

A new framework: challenging patents in changing times

01-01-2012Eldora Ellison and Eric Steffe

The America Invents Act was signed into law in September 2011, and many biotech companies are still trying to make sense of the new legislation. Eldora Ellison and Eric Steffe consider one of the most important changes.

Formal obligations: burdens on biotech patents

01-01-2012

The patentability of biotech inventions should meet substantive requirements such as novelty, inventive step and industrial applicability, but EPO developments suggest that formalities are increasingly important.

Is there life for medical diagnostic patents after Prometheus?

01-01-2012MaryAnne Armstrong

The Supreme Court’s much-anticipated Prometheus decision has prompted strong reactions among IP practitioners, as MaryAnne Armstrong, PhD, explains.

Life sciences in Europe: the key jurisdictions

01-05-2011

The European life sciences industry has a long history. Many of the major players trace their roots to before the war, and often began as agricultural or chemical companies. LSIPR takes a look at the leading jurisdictions.

Covering all the bases: An interview with BIO President Jim Greenwood

01-05-2011

BIO represents a broad constituency of biotechnology and life sciences companies. LSIPR talks to BIO president and CEO Jim Greenwood about patent reform, healthcare, court cases and plans for the future.

It’s good to litigate a patent or two

01-05-2011

Europe is home to many life sciences companies, so IP regimes throughout the continent’s jurisdictions need to provide cost-effective, speedy and certain litigation environments if patent disputes are to be satisfactorily settled.

Clinical trials in BioPharma

US01-05-2011Eric Steffe

A recent study revealed that biotechnology companies or universities discovered 42 percent of all innovative drugs approved by the US Food and Drug Administration (FDA) between 1998 and 2007.

US Patent Law changes appear imminent

US01-05-2011John Pegram and Mark Ellinger

US patent reform looks like it may finally be coming. John Pegram and Mark Ellinger explain the proposed changes.

Patenting genes and diagnostics

US01-05-2011Simon O’Brien and David Gass

As biotechnology patents continue to grow in importance, uncertainty remains on both sides of the Atlantic as to exactly what is patentable. Simon O’Brien and David Gass take a look.

A revolution: biotech patents in India

India01-05-2011Archana Shanker

It has taken a long time for India to develop a productive environment for biotechnology. But recent developments look to have put it on the right track. Archana Shanker explains.

Showing 261 to 270 of 273 results

LSIPR